Can CuO nanoparticles lead to epigenetic regulation of antioxidant enzyme system?
Copper has been used from ancient time in various applications. Scientists have exploited its means of exposure and consequences to living organisms. The peculiar property of nanomaterials that is a high surface to volume ratio has increased the range of application in products. Copper oxide nanoparticles (CuO NPs) are widely used in industrial applications such as semiconductor devices, gas sensor, batteries, solar energy converter, microelectronics, heat transfer fluids and consumer products. In contrast, acute toxicity of CuO NPs has also been reported. Subsequently, human and environmental health may be at a high risk. Their frequent use can also contaminate ecosystems. Therefore, the toxicity of CuO NPs needs to be thoroughly understood. In this review, we have tried to discuss the recent facts and mechanism that have been explored for CuO NPs-induced toxicity at a cellular, in vivo and ecotoxicological level. Accordingly, the main cause for induction of toxicity by CuO NPs is the generation of reactive oxygen species (ROS) followed by the mitochondrial destruction that leads to apoptosis via the intrinsic pathway or under the condition such as hypoxia cell on exposure to CuO NPs may commit to necrosis. Moreover, CuO NPs also result in activation of MAPK pathways, ERKs and JNK/SAPK thus play an important role in the activation of AP-1. Furthermore, CuO NPs also leads to up-regulation of p53 and caspase three genes. Therefore, careful measures are required to explore omic technology to understand the molecular mechanism of the deleterious effects caused by CuO NPs. Copyright © 2016 John Wiley & Sons, Ltd.
School of Arts and Science, Division of Biology and Life Sciences, Ahmedabad University, Ahmedabad, 380009, India.
Sandesh
S
Chibber
School of Arts and Science, Division of Biology and Life Sciences, Ahmedabad University, Ahmedabad, 380009, India.
Rishi
R
Shanker
D000818:Animals; D000975:Antioxidants / Q000378:metabolism*; D003300:Copper / Q000633:toxicity*; D004305:Dose-Response Relationship, Drug; D004785:Environmental Pollutants / Q000633:toxicity*; D044127:Epigenesis, Genetic / Q000187:drug effects*; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects*; D006801:Humans; D053758:Nanoparticles / Q000633:toxicity*; D017382:Reactive Oxygen Species / Q000378:metabolism
D000975:Antioxidants; D004785:Environmental Pollutants; D017382:Reactive Oxygen Species; D003300:Copper; C030973:cupric oxide
CuO NP; ROS; apoptosis; epigenetic; tissue necrosis